Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biocept Inc (BIOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3457
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It serves cancer diagnostic assays to oncologists and other physicians; hospitals, and cancer centers. Biocept also provides clinical trial and research services to pharmaceutical and biopharmaceutical companies; and clinical research organizations. Biocept is headquartered in San Diego, California, the US.

Biocept Inc (BIOC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biocept Inc, Medical Devices Deals, 2012 to YTD 2018 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biocept Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Biocept Enters into Research Agreement with University of Minnesota 11
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 12
Biocept Enters into Partnership with Dana-Farber Cancer Institute 13
Equity Offering 14
Biocept Raise USD11.6 Million in Rights Offering of Units 14
Biocept Plans to Raise USD50 Million in Public Offering of Securities 16
Biocept Prices Public Offering of Shares for USD3.3 Million 17
Biocept Prices USD3.3 Million in Public Offering of Shares 19
Biocept Plans to Raise Funds through Private Placement of Shares 20
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 21
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept to Raise USD15 Million in Public Offering of Shares 25
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 26
Biocept Completes IPO For US$19 Million 28
Biocept Inc – Key Competitors 29
Biocept Inc – Key Employees 30
Biocept Inc – Locations And Subsidiaries 31
Head Office 31
Recent Developments 32
Financial Announcements 32
Aug 14, 2018: Biocept reports second quarter 2018 financial results 32
May 15, 2018: Biocept Announces First Quarter 2018 Financial Results 35
Mar 28, 2018: Biocept Reports 2017 Fourth Quarter and Full Year Financial Results 37
Nov 09, 2017: Biocept Reports Third Quarter 2017 Financial Results 40
Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results 43
May 11, 2017: Biocept Reports First Quarter 2017 Financial Results 46
Mar 07, 2017: Biocept Reports Fourth Quarter and Full Year 2016 Financial Results 48
Corporate Communications 50
Oct 11, 2017: Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept’s Clinical Advisory Board 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Biocept Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biocept Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Biocept Inc, Medical Devices Deals, 2012 to YTD 2018 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biocept Enters into Research Agreement with University of Minnesota 11
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 12
Biocept Enters into Partnership with Dana-Farber Cancer Institute 13
Biocept Raise USD11.6 Million in Rights Offering of Units 14
Biocept Plans to Raise USD50 Million in Public Offering of Securities 16
Biocept Prices Public Offering of Shares for USD3.3 Million 17
Biocept Prices USD3.3 Million in Public Offering of Shares 19
Biocept Plans to Raise Funds through Private Placement of Shares 20
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 21
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept to Raise USD15 Million in Public Offering of Shares 25
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 26
Biocept Completes IPO For US$19 Million 28
Biocept Inc, Key Competitors 29
Biocept Inc, Key Employees 30

List of Figures
Biocept Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biocept Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biocept Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yellowstone Valley Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Yellowstone Valley Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Harel Insurance Investments and Financial Services Ltd:企業のM&A・事業提携・投資動向
    Harel Insurance Investments and Financial Services Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harel Insurance Investments and Financial Services Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes bus …
  • Grupo Grana y Montero SAA (GRAMONC1):石油・ガス:M&Aディール及び事業提携情報
    Summary Grupo Grana y Montero SAA (Grana y Montero) is a group company that provides engineering and infrastructure services. The company’s business areas include engineering and construction, infrastructure development, real estate and technical services. It provides engineering procurement and con …
  • A.P. Moller – Maersk AS (MAERSK B):石油・ガス:M&Aディール及び事業提携情報
    Summary A.P. Moller - Maersk AS (APM) is an integrated transport and logistics company with operations in container shipping and ports operating through a subsidiary and affiliates. It transports dry cargo, refrigerated cargo, special cargo and also conducts used container sales and supports intermo …
  • Mckesson Europe AG (CLS1):製薬・医療:M&Aディール及び事業提携情報
    Summary Mckesson Europe AG (Mckesson Europe), formerly known as Celesio AG, is a provider of logistics and services to healthcare and pharmaceutical sectors across Europe. The company is involved in providing distribution solution to its wholesale, institutional and retail customers and delivering p …
  • Western Gas Equity Partners LP:企業の戦略・SWOT・財務情報
    Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report Summary Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Africa Oil Corp (AOI):企業の財務・戦略的SWOT分析
    Summary Africa Oil Corp (AOC) is an oil and gas company that discovers, develops, explores and produces oil and gas assets. The company has oil discoveries in Ekales, Agete, Amosing, Ewoi wells in the Lokichar Basin, and others. It owns and operates various blocks including block 9, block 10A, block …
  • Corvel Corporation:企業の戦略・SWOT・財務分析
    Corvel Corporation - Strategy, SWOT and Corporate Finance Report Summary Corvel Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Nippon Yusen Kabushiki Kaisha:企業の戦略・SWOT・財務情報
    Nippon Yusen Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report Summary Nippon Yusen Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • British Broadcasting Corporation:企業の戦略的SWOT分析
    British Broadcasting Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • FDC Ltd (FDC):企業の財務・戦略的SWOT分析
    Summary FDC Ltd (FDC) is a pharmaceutical company that manufactures and markets of oral rehydration salts, ophthalmics and functional foods. The company also provides active pharmaceuticals ingredients (APIs). It provides products for the therapeutic segments of anti-infectives, gastrointestinals, o …
  • AMC Entertainment Holdings, Inc.:企業の戦略・SWOT・財務分析
    AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • LivePerson, Inc. (LPSN):企業の財務・戦略的SWOT分析
    LivePerson, Inc. (LPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • BHP:企業の戦略・SWOT・財務情報
    BHP - Strategy, SWOT and Corporate Finance Report Summary BHP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • Sumitomo Electric Industries Ltd (5802):企業の財務・戦略的SWOT分析
    Sumitomo Electric Industries Ltd (5802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • The GPT Group (GPT):企業の財務・戦略的SWOT分析
    The GPT Group (GPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • J. Knipper and Company Inc:企業の戦略的SWOT分析
    J. Knipper and Company Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hill’s Pet Nutrition, Inc.:企業の戦略的SWOT分析
    Hill's Pet Nutrition, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Peel Hotels Plc:企業の戦略・SWOT・財務情報
    Peel Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Peel Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆